NICE says that Lokelma can be used for non-dialysed patients with CKD or heart failure who have persistent hyperkalaemia with a potassium level of 6.0 mmol/litre or more that is preventing them ...

Patients who achieved normokalemia – normal potassium rates – during the first 48 hours with Lokelma 10g three times daily, progressed to the 28-day maintenance phase of the trial.